Europe Down Syndrome Market to 2032
Overview
The Europe Down Syndrome Market is expected to reach a 1,382.73 USD Million by 2032 and is projected to grow at a CAGR of 22.76% from 2025 to 2032.
Revenue, 2024 (USD Million)
474.31
Forecast, 2032 (USD Million)
1,382.73
CAGR, 2024 - 2032
22.76%
Report Coverage
Europe
Europe Down Syndrome Market 2018-2032 USD Million
Europe Down Syndrome Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 474.31 USD Million
- Projected Market Size (2032): 1,382.73 USD Million
- CAGR (2025-2032): 22.76%
Key Findings of Europe Down Syndrome Market
- The Europe Down Syndrome Market was valued at 474.31 USD Million in 2024.
- The Europe Down Syndrome Market is likely to grow at a CAGR of 22.76% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Trisomy 21 in Disease Type Segment accounted for the largest share of the market with a revenue of 445.00 USD Million
- The fastest growing segment Therapy Centers in End User Segment grew Fastest with a CAGR of 26.84% during the forecast period from 2024 to 2032.
Europe Down Syndrome Market Scope
Europe Down Syndrome Market Segmentation & Scope
Treatment
- Therapy
- Diagnosis
Disease Type
- Mosaic Down Syndrome
- Translocation Down Syndrome
- Trisomy 21
Distribution Channel
- Others
- Retail Sales
- Direct Tender
End User
- Others
- Therapy Centers
- Homecare Setting
- Clinics
- Hospital
Europe Down Syndrome Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 474.31 USD Million |
| Market Value in 2032 | 1,382.73 USD Million |
| CAGR (2025-2032) | 22.76% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Treatment, Disease Type, Distribution Channel, End User |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 474.31 USD Million in 2024
- Key Country: Germany, leading in terms of revenue with value of 102.66 USD Million in 2024.
Segments and Scope
-
Europe Down Syndrome Market to 2032, By Treatment
- Diagnosis is the largest segment in Europe Down Syndrome Market to 2032 with a revenue of 424.36 USD Million in the year 2024.
- Therapy is the Fastest growing segment in Europe Down Syndrome Market to 2032 with a Growth rate of 22.49 % in forecast period 2025-2032.
-
Europe Down Syndrome Market to 2032, By Disease Type
- Trisomy 21 is the largest segment in Europe Down Syndrome Market to 2032 with a revenue of 445.00 USD Million in the year 2024.
- Trisomy 21 is the Fastest growing segment in Europe Down Syndrome Market to 2032 with a Growth rate of 23.04 % in forecast period 2025-2032.
-
Europe Down Syndrome Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Europe Down Syndrome Market to 2032 with a revenue of 355.09 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Europe Down Syndrome Market to 2032 with a Growth rate of 24.26 % in forecast period 2025-2032.
-
Europe Down Syndrome Market to 2032, By End User
- Hospital is the largest segment in Europe Down Syndrome Market to 2032 with a revenue of 277.08 USD Million in the year 2024.
- Therapy Centers is the Fastest growing segment in Europe Down Syndrome Market to 2032 with a Growth rate of 22.57 % in forecast period 2025-2032.
Europe Down Syndrome Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| PerkinElmer Inc. | |||
| Illumina, Inc. | |||
| Thermo Fisher Scientific Inc. | |||
| Abbott | |||
Europe Down Syndrome Market Geographical Sales Distribution, 2018-2032 USD Million
Europe Down Syndrome Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Europe Down Syndrome Market is segmented based on Segmentation Treatment, Disease Type, Distribution Channel, End User.
Europe Down Syndrome Market was valued at USD 474.31(Revenue in USD Million) in 2020.
Europe Down Syndrome Market is projected to grow at a CAGR of 22.76% during the forecast period of 2024 to 2032.
The Trisomy 21 segment is expected to dominate the Europe Down Syndrome Market, holding a largest market share of 445.00 USD Million in 2024
Europe Down Syndrome Market Scope
Europe Down Syndrome Market Segmentation & Scope
Treatment
- Therapy
- Diagnosis
Disease Type
- Mosaic Down Syndrome
- Translocation Down Syndrome
- Trisomy 21
Distribution Channel
- Others
- Retail Sales
- Direct Tender
End User
- Others
- Therapy Centers
- Homecare Setting
- Clinics
- Hospital
Frequently Asked Questions
The Europe Down Syndrome Market is segmented based on Segmentation Treatment, Disease Type, Distribution Channel, End User.
Europe Down Syndrome Market was valued at USD 474.31(Revenue in USD Million) in 2020.
Europe Down Syndrome Market is projected to grow at a CAGR of 22.76% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Down Syndrome Market for final year is USD 1,382.73 (USD Million).
Europe Down Syndrome Market Company Profiling
Frequently Asked Questions
The Europe Down Syndrome Market is segmented based on Segmentation Treatment, Disease Type, Distribution Channel, End User.
Europe Down Syndrome Market was valued at USD 474.31(Revenue in USD Million) in 2020.
Europe Down Syndrome Market is projected to grow at a CAGR of 22.76% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Down Syndrome Market for final year is USD 1,382.73 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.